Clinical Trials Logo

Filter by:
NCT ID: NCT05336435 Recruiting - Clinical trials for Coronary Artery Disease

A Study of Population and Sex-specific Troponin Cutoffs for Ruling Out Acute Myocardial Infarction

DANSPOT
Start date: April 1, 2022
Phase: N/A
Study type: Interventional

Acute myocardial infarction (MI) is defined as a rise and/or fall in cardiac troponins (cTn) with at least one value above the 99th percentile upper reference limit (URL) in the context of symptoms or clinical evidence of myocardial ischemia. The URL is based on measurements in a healthy reference population. Currently, a sex-uniform manufacturer provided 99th percentile URL of troponin is utilized at Danish hospitals as a diagnostic cutoff for acute MI for both men and women. Reportedly, healthy men have twofold the troponin level compared to healthy women, suggesting that the use of a uniform URL for troponins may lead to the under-diagnostication of acute MI in women and potentially over-diagnostication in men. The purpose of the DANSPOT study is to evaluate the clinical effect on diagnosis, treatment and outcomes in men and women presenting with acute MI of implementing international guidelines recommendations of sex-specific 99th percentile URLs for troponin into clinical practice. First, to determine the sex-specific 99th percentile URLs of troponins based on a healthy Danish reference population, blood samples from Danish blood donors, were analyzed using one troponin T assay and four troponin I assays. Second, the DANSPOT study is a nationwide cluster-randomized trial with "stepped-wedge" design with participation of all 22 Danish hospital laboratories and associated departments of cardiology. With one-month intervals, each of 22 centers are randomized to shift from the presently applied uniform 99th percentile URL of troponin to our newly determined population and sex-specific 99th percentiles URLs. Each patient is followed in Danish registries for 12 months after first admission. The hypothesis of the DANSPOT study is that implementation of population and sex-specific 99th URLs for troponin, will ensure that the right patients receive the right treatment. The investigators expect to detect significantly more women with acute MI, theoretically resulting in a more accurate diagnosis and treatment of women and men with acute MI.

NCT ID: NCT05336474 Recruiting - Difficult Airway Clinical Trials

Anatomical and Ultrasonographic Parameters to Predict Difficult Airway in Pediatrics

Start date: April 1, 2022
Phase:
Study type: Observational

This study was designed to assess the accuracy of ultrasonographic parameters in combination to clinical parameters in the prediction of difficult airway in pediatric population. All patients underwent a standard airway examination and sonographic airway assessment preoperatively and the predictive values for difficult airway of these methods were recorded.

NCT ID: NCT05336539 Recruiting - Colorectal Cancer Clinical Trials

A Community Population Screening Cohort Study Based on Polygene Methylation Detection for Colorectal Cancer in Yangzhou

Start date: April 1, 2022
Phase:
Study type: Observational

This is a cross-sectional cohort study based on community population jointly developed by Northern Jiangsu People's Hospital and Shanghai Kunyuan Biological Technology Co., LTD. This study will verify the real world results of polygene methylation detection of colorectal cancer in a large prospective cohort of community population, which is expected to enroll 80,000 permanent residents in Yangzhou city. The preliminary design period of the study is 5 years. In this study, questionnaire survey and polygene methylation test of colorectal cancer were used as the primary screening method, and colonoscopy was used as the further validation examination method to screen colorectal cancer and precancerous lesions. The diagnosis and outcome of all lesions were based on colonoscopy and pathological examination. The evaluation indexes include sensitivity, specificity, detection rate of precancerous lesions and adenoma.

NCT ID: NCT05337436 Recruiting - Clinical trials for Chronic Kidney Diseases

Ionized Magnesium Balance During Hemodialysis Session

MAGNESIR
Start date: April 1, 2022
Phase:
Study type: Observational

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the balance of total and ionized magnesium according to different types of dialysate used in clinical practice (acetate + Mg 0.50 or 0.75 mM vs citrate + Mg 0.50 ou 0.75 mM)

NCT ID: NCT05337475 Recruiting - Swallowing Disorder Clinical Trials

Feeding and Swallowing Problems in Infants With Laryngomalacia

Start date: April 1, 2022
Phase:
Study type: Observational

Observational cross-sectional study Infants with laryngomalacia Feeding and swallowing assessment

NCT ID: NCT05339009 Recruiting - Clinical trials for Chronic Kidney Disease 5D

Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient

REFILBIOADM
Start date: April 1, 2022
Phase:
Study type: Observational

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) the predictive value of bio-adrenomedullin (bio-ADM) level on vascular refilling rate.

NCT ID: NCT05340491 Recruiting - Clinical trials for Nasopharyngeal Carcinoma

Chemoradiotherapy Plus Anti-PD1 in Recurrent NPC: A Multicenter, Open-label, Randomised, Controlled, Phase III Trial

Start date: April 1, 2022
Phase: Phase 3
Study type: Interventional

This is a multicenter, open-label, randomized, controlled, phase III trial. The purpose of this trial is to evaluate the efficacy and toxicity of anti-PD-1 antibody combined with chemoradiotherapy versus chemoradiotherapy alone in recurrent nasopharyngeal carcinoma patients.

NCT ID: NCT05340556 Recruiting - Clinical trials for Recurrent Pregnancy Loss, Not Pregnant

Microchimerism in Patients With Recurrent Pregnancy Losses

Start date: April 1, 2022
Phase: N/A
Study type: Interventional

This pilot study aims to evaluate if microchimeric cells in a patient with recurrent pregnancy loss (RPL) can be detected by the blood analysis for the presence of the DYS14 gene and the use of indel-panel methods and also, to examine if this method can distinguish the cell's origin; comparing gene sequence from the patient's firstborn son or her older brother. In addition, the pilot study will provide the investigators with information and experience necessary for a subsequent main study to be conducted.

NCT ID: NCT05341050 Recruiting - MMR on 12 Month Clinical Trials

A Study on the Withdrawal of Second-generation Tyrosine Kinase Inhibitors After Dose Reduction in Patients With CML

Start date: April 1, 2022
Phase:
Study type: Observational

patients with Ph+ CML-CP who have been treated with second-generation TKIs (nilotinib, dasatinib) for at least 3 years and maintains MMR for at least 2 years, continue to be treated with halved dose for 12 months, and then stop for 12 months.

NCT ID: NCT05341479 Recruiting - Clinical trials for Oropharynx Carcinoma

An Observational Study of Clinical Treatments for Patients With Oropharyngeal Carcinoma

Start date: April 1, 2022
Phase:
Study type: Observational

This is a prospective, observational study evaluating the effect and efficiency of different clinical treatments for patients with oropharyngeal carcinoma (OPC). The selection of treatment for individual patient is based on tumor characteristics (tumor size and tumor location), a complete assessment of therapeutic effects (treatment effectiveness, possible dysfunction after operation, function maintenance, complications, etc.), and the preferences of doctors and patients.